Literature DB >> 16168209

On the critical assessment of the impact of the recent European Union Tissues and Cells Directive.

Pushpa M Bhargava1.   

Abstract

In this commentary it is argued that David Mortimer's contention (Mortimer, 2005) that 'there are grave problems with the feasibility, effectiveness and likely adverse impact of applying clean room and air quality standards to assisted conception facilities, especially IVF laboratories', as envisaged in the European Union's Tissues and Cells Directive (2004), is fully justified. As he says, 'effective regulations need to recognize what is impossible, what is possible and what is realistic'. The Directive, while necessary in principle, does not take into account the fact that what may appear to be ideal from a narrow technical point of view may, in fact, in a larger context, defeat its purpose by actually being harmful.

Entities:  

Mesh:

Year:  2005        PMID: 16168209     DOI: 10.1016/s1472-6483(10)60953-4

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  1 in total

1.  Beware of the commercialization of human cells and tissues: situation in the European Union.

Authors:  Jean-Paul Pirnay; Alain Vanderkelen; Nadine Ectors; Christian Delloye; Denis Dufrane; Etienne Baudoux; Michel Van Brussel; Michael P Casaer; Daniel De Vos; Jean-Pierre Draye; Thomas Rose; Serge Jennes; Pierre Neirinckx; Geert Laire; Martin Zizi; Gilbert Verbeken
Journal:  Cell Tissue Bank       Date:  2012-06-21       Impact factor: 1.522

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.